⏳ The countdown has officially begun! BioFIT, Europe’s leading partnering event for early-stage deals and investment rounds bringing together 1,000 international Life Sciences players, is just around the corner. The event kicks off next Tuesday 12^th December in Marseille, France, followed by its digital day on December 15^th. 

Don’t wait any longer to register and have the opportunity to meet with key players such as: AbbVie, AdBio partners, Andera Partners, Apollo Health Ventures, Bayer, Astellas, BIOASTER, Biofortis, Boehringer Ingelheim, CAPTECH Santé Nutrition, Charles River Laboratories, CNRS, EQT Life Sciences, EMBLEM Technology Transfer, Fund+, Eurofins, Genfit, GSK Glaxo Smith Kline, High-Tech Gründerfonds, INRAE Transfer, Ipsen, Jeito, Merck, MSD, Novo Holdings, Novo Nordisk, Pfizer, Réseau SATT, Roche, Sofinnova Partners, Spartners by Servier & Biolabs, Sterling Pharma Solutions, Thermo Fischer Scientific, Trinity College Dublin, Virbac, X’PROCHEM, Zoetis… and many more.

GENFIT is proud to support the next edition of BioFIT that will take place this year in Marseille, France, on December 12^th and 13^th, 2023.

Dear Colleagues and BioFIT delegates,

We’re excited to be back at BioFIT to meet new partners who share our passion for innovation and collaboration.

Our goal is to discover and develop breakthroughs that solve the biggest challenges in human and animal health. That starts with innovation. We’re committed to investing in and advancing emerging science. And we look forward to connecting with the biotechs, academics, TTOs and research institutions attending BioFIT to discover how we can work together to advance innovation and provide solutions to address the many areas of unmet need that remain in human and animal health.

Register on the BioFIT partnering platform to meet us in person or virtually. Our onsite meeting booth is number 67.

You can also hear from our team as they take part in key conference sessions:
Join Hervé Poulet, Director Strategic Partnering, Animal Health for the discussion on: Sourcing innovations from a more mature human health market to build assets and start-ups in animal health, on Tuesday, December 12^th, 2.00 – 3.00 pm.
Join Julie Edwards, Director of Alliance Management, for the discussion on: Best practices in managing early-stage academia-industry collaborations, on Wednesday, December 13^th, 3.30 – 4.30 pm.
We look forward to meeting you!

Servier is looking for partners

Servier is an international pharmaceutical player highly active in various collaborative approaches. Indeed, the Group is convinced that the best way to achieve fast-paced innovation oriented to meet patient needs is through collaboration and constant dialogue between those involved in health care in both the public and private sectors. That is why Servier takes an open and collaborative approach to innovation.

Partnerships

Servier has forged many alliances and is always actively looking for partnerships with world-class academic researchers, technology transfer and development offices, non-profit foundations, company builders, venture capitalists and strategic biotechnology and pharma partners.

Our partnership strategy centers around a single objective, to ramp up the speed with which we develop treatments that significantly improve patients’ quality of life. We take a people-oriented approach to our partnerships, and we focus on creating win-win situations by pooling our expertise.

This year again BioFIT, the leading European partnering event for early-stage deals and investment rounds in the Life Sciences field, will showcase the latest innovative projects selected by its prestigious Steering Committee. 

Protein therapeutics are paving the way for new medical research, contributing to the discovery of more effective treatments. They embody the future of medicine, promising a better quality of life for many people.

However, their production is a complex task that presents many challenges such as their design, purification, solubilization and stability.

Let X’PROCHEM be your partner in the design and manufacturing of your therapeutic proteins. Rest assured, we pledge to deliver proteins of high purity, free from biological contaminants, endotoxins, and isoforms.

Come and meet us on December 12^th & 13^th, 2023 in Marseille to learn more about our solutions.

Participating in BioFIT, the leading European partnering event for early-stage deals and investment rounds in the Life Sciences field, gives you the opportunity to attend several events organised by the main players in the sector: